ArticleFrontiers in oncology2026
Development and validation of a machine learning-based predictive model for early outcomes following combined suction-assisted lipectomy and lymphovenous anastomosis in breast cancer-related lymphedema: a retrospective cohort study.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Breast cancer-related lymphedema (BCRL) significantly compromises quality of life. Although combined suction-assisted lipectomy (SAL) and lymphovenous anastomosis (LVA) is effective, outcomes vary considerably among patients. Currently, tools for early postoperative risk stratification are lacking. Methods: We retrospectively reviewed data from BCRL patients who underwent combined SAL and LVA at Beijing Shijitan Hospitalfrom June 2018 to June 2025. Predictive variables were selected using the Least Absolute Shrinkage and Selection Operator (LASSO) regression combined with bootstrap resampling (B = 1,000). Seven algorithms-including logistic regression (LR), decision tree (DT), random forest (RF), eXtreme Gradient Boosting (XGBoost), Light Gradient Boosting Machine (LightGBM), support vector machine (SVM), and artificial neural network (ANN) were compared. Model performance was evaluated using the area under the receiver operating characteristic curve (AUC), calibration plots, decision curve analysis (DCA), and Brier score. SHapley Additive exPlanations (SHAP) analysis was conducted for model interpretation, and a web-based prediction tool was developed. Results: A total of 300 patients were enrolled (training set: n=211; validation set: n=89). The rate of satisfactory outcomes at 6 months was 72.3%. LASSO and bootstrap validation identified three stable predictors: postoperative excess limb volume (selection frequency: 100%), disease duration (83.6%), and disease severity grade (83.4%). Among the seven models, SVM exhibited the optimal balance of discrimination and clinical utility in the validation set: AUC 0.891 (95% CI: 0.812-0.970), sensitivity 90.8%, specificity 62.5%, F1-score 0.887, and Brier score 0.119. DCA indicated net clinical benefit within the threshold range of 0.1-0.6. Although ANN achieved a higher AUC than SVM (0.903 vs. 0.891) (DeLong test, P = 0.532), SVM demonstrated superior sensitivity (90.8% vs. 89.2%), F1-score (0.887 vs. 0.879), and Cohen's kappa (0.555 vs. 0.531).Furthermore, SVM's structural risk minimization principle conferred superior generalization stability compared with ANN's empirical risk minimization, making it more suitable for small-sample clinical settings. SHAP analysis revealed that postoperative excess volume was the strongest predictor. Conclusion: The 3-variable SVM model effectively predicts 6-month outcomes following combined surgery for BCRL. Integrated with SHAP analysis and a web-based tool, this model enables early postoperative risk stratification to identify high-risk patients requiring closer monitoring, providing a reference for future standardized rehabilitation protocols.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.